No abstract available
MeSH terms
-
AIDS-Related Opportunistic Infections / drug therapy
-
AIDS-Related Opportunistic Infections / physiopathology
-
AIDS-Related Opportunistic Infections / virology
-
Acquired Immunodeficiency Syndrome / complications*
-
Acquired Immunodeficiency Syndrome / drug therapy
-
Acquired Immunodeficiency Syndrome / physiopathology
-
Acquired Immunodeficiency Syndrome / virology
-
Adult
-
Antineoplastic Agents / therapeutic use*
-
Antiretroviral Therapy, Highly Active
-
Antiviral Agents / therapeutic use*
-
Burkitt Lymphoma / drug therapy
-
Burkitt Lymphoma / physiopathology
-
Burkitt Lymphoma / virology
-
Cidofovir
-
Cytosine / analogs & derivatives
-
Cytosine / therapeutic use*
-
HIV Long-Term Survivors
-
HIV Protease Inhibitors / therapeutic use
-
Herpesvirus 4, Human / isolation & purification
-
Herpesvirus 8, Human / isolation & purification
-
Humans
-
Interferon-alpha / therapeutic use*
-
Lymphoma, B-Cell / drug therapy*
-
Lymphoma, B-Cell / physiopathology
-
Lymphoma, B-Cell / virology
-
Male
-
Organophosphonates*
-
Organophosphorus Compounds / therapeutic use*
-
Pleural Effusion
-
Sarcoma, Kaposi / drug therapy
-
Sarcoma, Kaposi / physiopathology
-
Sarcoma, Kaposi / virology
-
Time Factors
Substances
-
Antineoplastic Agents
-
Antiviral Agents
-
HIV Protease Inhibitors
-
Interferon-alpha
-
Organophosphonates
-
Organophosphorus Compounds
-
Cytosine
-
Cidofovir